CJC-1295 DAC 5mg
CJC-1295 DAC is a long-acting GHRH analogue designed to provide extended growth-hormone stimulation through its Drug Affinity Complex (DAC) attachment. This modification enhances its half-life dramatically, allowing sustained GH-release patterns in research settings. This peptide has ideal research in these categories:
- – Muscle Growth & Performance
- – Recovery & Repair
- – Longevity Support
Understanding This Peptide
The DAC variant binds to serum albumin, extending its durability within the body and allowing for prolonged GH-receptor interaction. Its long-acting nature makes it a valuable tool for examining continuous growth-hormone elevation rather than pulsatile stimulation.
Mechanism of Action
CJC-1295 DAC binds albumin via the DAC structure, ensuring slow, steady release and extended receptor activation. This creates a sustained GH increase, supporting research into long-term growth-hormone pathways, recovery, and metabolic modulation.
Scientific Interest
Researchers appreciate this peptide for its unique pharmacokinetic profile, allowing long-duration GH elevation not achievable through traditional GHRH analogues. It provides a distinct model for studying chronic GH-related effects.
Research Focus & Clinical Landscape
Active areas of investigation include:
- – long-acting GH stimulation
- – increased IGF-1 expression
- – cellular repair and recovery
- – metabolic enhancement
- – regenerative biology
- – extended hormone signaling
Its durability and binding properties continue to attract research interest worldwide.
Quality, Craftsmanship & Purity
CJC-1295 DAC is produced under strict GMP guidelines with >98% purity and third-party testing to confirm identity, potency, and consistency across batches.
Final Insight
CJC-1295 DAC provides an elegant, long-acting GH-research model, offering extended activity for studies requiring sustained hormonal signaling.